Immunity to infections on secretory surfaces.
D000336:Aerosols; D000818:Animals; D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D000992:Antitoxins; D001419:Bacteria / Q000276:immunology; D001428:Bacterial Vaccines / Q000008:administration & dosage; D002462:Cell Membrane / Q000276:immunology; D003140:Communicable Disease Control; D003141:Communicable Diseases / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D007109:Immunity; D007111:Immunity, Cellular; D007114:Immunization; D007120:Immunochemistry; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A; D007073:Immunoglobulin E; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007239:Infections / Q000276:immunology*; D051379:Mice; D009092:Mucous Membrane / Q000276:immunology; D009500:Neutralization Tests; D009895:Opsonin Proteins; D011817:Rabbits; D051381:Rats; D014613:Vaccines, Attenuated; D014765:Viral Vaccines / Q000008:administration & dosage; D014780:Viruses / Q000276:immunology
D000336:Aerosols; D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D000992:Antitoxins; D001428:Bacterial Vaccines; D007106:Immune Sera; D007070:Immunoglobulin A; D009895:Opsonin Proteins; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D007073:Immunoglobulin E